104 related articles for article (PubMed ID: 21438927)
1. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
Wu XM; Liao YW; Ji KQ; Li GF; Zang B
J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
[TBL] [Abstract][Full Text] [Related]
2. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
3. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
[TBL] [Abstract][Full Text] [Related]
4. CCK stimulates growth of both the pancreas and the liver.
Ohlsson B; Rehfeld JF; Axelson J
Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
[TBL] [Abstract][Full Text] [Related]
5. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog.
Hughes CA; Bates T; Dowling RH
Gastroenterology; 1978 Jul; 75(1):34-41. PubMed ID: 122602
[TBL] [Abstract][Full Text] [Related]
7. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
9. Influence of an intravenous infusion of amino acids and glucose on the pancreatic exocrine in rats.
Fan BG; Ake AS
Chin Med J (Engl); 2004 Nov; 117(11):1659-64. PubMed ID: 15569482
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
Wan S; Coleman FH; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
[TBL] [Abstract][Full Text] [Related]
11. Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression.
Baumler MD; Nelson DW; Ney DM; Groblewski GE
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G857-66. PubMed ID: 17138970
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
[TBL] [Abstract][Full Text] [Related]
13. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
Ohlsson B; Rehfeld JF; Axelson J
Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
[TBL] [Abstract][Full Text] [Related]
15. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
16. Are radioligand antagonist/agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists?
Patel S; Chapman KL; Smith AJ; Bailey I; Freedman SB
Regul Pept; 1996 Aug; 65(1):29-35. PubMed ID: 8876033
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
18. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.
Doty JE; Pitt HA; Porter-Fink V; Denbesten L
Ann Surg; 1985 Jan; 201(1):76-80. PubMed ID: 3917658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
